Literature DB >> 18314439

Critical lessons from the ENHANCE trial.

Philip Greenland1, Donald Lloyd-Jones.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18314439     DOI： 10.1001/jama.299.8.953

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Simvastatin with or without ezetimibe in familial hypercholesterolemia (the ENHANCE trial).

Authors:  John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2009-03       Impact factor: 5.113

Review 2.  Reporting bias in medical research - a narrative review.

Authors:  Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal:  Trials       Date:  2010-04-13       Impact factor: 2.279

3.  Unhealthy marketing of pharmaceutical products: An international public health concern.

Authors:  Shai Mulinari
Journal:  J Public Health Policy       Date:  2016-02-25       Impact factor: 2.222

4.  The importance of clinical trial data sharing: toward more open science.

Authors:  Joseph S Ross; Richard Lehman; Cary P Gross
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-03-01

5.  Study of the strength of the evidence and the redundancy of the research on pharmacological treatment for Alzheimer's disease: a cumulative meta-analysis and trial sequential analysis.

Authors:  Lídia Blanco-Silvente; Xavier Castells; Josep Garre-Olmo; Joan Vilalta-Franch; Marc Saez; Maria Antònia Barceló; Dolors Capellà
Journal:  Eur J Clin Pharmacol       Date:  2019-08-21       Impact factor: 2.953

6.  Promoting transparency in pharmaceutical industry-sponsored research.

Authors:  Joseph S Ross; Cary P Gross; Harlan M Krumholz
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

7.  Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.

Authors:  Joseph S Ross; Sharon G Frazee; Susan B Garavaglia; Rebecca Levin; Haik Novshadian; Cynthia A Jackevicius; Glen Stettin; Harlan M Krumholz
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

Review 8.  Risk factor management to prevent first stroke.

Authors:  Tatjana Rundek; Ralph L Sacco
Journal:  Neurol Clin       Date:  2008-11       Impact factor: 3.806

9.  Quantitative impact of cardiovascular risk factors and vascular closure devices on the femoral artery after repeat cardiac catheterization.

Authors:  Klaus A Tiroch; Michael E Matheny; Frederic S Resnic
Journal:  Am Heart J       Date:  2010-01       Impact factor: 4.749

10.  Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?

Authors:  Michel de Lorgeril; Patricia Salen; Pascal Defaye; Mikael Rabaeus
Journal:  BMC Med       Date:  2013-01-04       Impact factor: 8.775
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.